Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 1.00 |
| ▸ | TKT | P29401 | 9/20 | 0.85 |
| ▸ | LMNA | P02545 | 1/20 | 0.85 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Monophosphothiamine SCHEMBL94444 | 1.00 | TDP1 (1.00) | TDP1TKTLMNAHSP90AA1ALDH1A1 | |
| Monophosphothiamine SCHEMBL5084549 | 0.99 | TDP1 (0.98) | TDP1TKTLMNAHSP90AA1ALDH1A1 | |
| Monophosphothiamine SCHEMBL23151820 | 0.99 | TDP1 (0.98) | TDP1TKTLMNAHSP90AA1ALDH1A1 | |
| Monophosphothiamine SCHEMBL29733068 | 0.99 | TDP1 (0.98) | TDP1TKTLMNAHSP90AA1ALDH1A1 | |
| Monophosphothiamine SCHEMBL94443 | 0.99 | TDP1 (0.98) | TDP1TKTLMNAHSP90AA1ALDH1A1 | |
| Monophosphothiamine SCHEMBL399485 | 0.98 | TDP1 (0.96) | TDP1TKTLMNAHSP90AA1ALDH1A1 | |
| Monophosphothiamine SCHEMBL23151818 | 0.98 | TDP1 (0.96) | TDP1TKTLMNAHSP90AA1ALDH1A1 | |
| Monophosphothiamine SCHEMBL4302194 | 0.98 | TDP1 (0.96) | TDP1TKTLMNAHSP90AA1ALDH1A1 | |
| Monophosphothiamine SCHEMBL3681710 | 0.98 | TDP1 (0.96) | TDP1TKTLMNAHSP90AA1ALDH1A1 | |
| Monophosphothiamine SCHEMBL23151777 | 0.98 | TDP1 (0.96) | TDP1TKTLMNAHSP90AA1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 231 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4638794-A1 | PALLADIUM CATALYST COMPOSITIONS AND METHODS FOR SEQUENCING BY SYNTHESIS | Illumina, Inc. (US) | 2025-10-29 | — | — | EP | claimed |
| EP-4520819-A1 | CHEMICAL-ENZYME COUPLING METHOD FOR SYNTHESIZING ERGOTHIONEINE | Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences (CN) | 2025-03-12 | — | — | EP | claimed |
| CN-119095982-A | Palladium catalyst compositions and methods for sequencing-by-synthesis | 伊路米纳有限公司 | 2024-12-06 | — | — | CN | claimed |
| WO-2024191956-A2 | MALODOR COUNTERACTING COMPOSITION | SKYESTER, INC. (US) | 2024-09-19 | — | — | WO | claimed |
| CN-118447932-A | Method and system for filling material in epoxy molding compound for electronic packaging | 武创芯研科技(武汉)有限公司 | 2024-08-06 | — | — | CN | claimed |
| US-20240247311-A1 | PALLADIUM CATALYST COMPOSITIONS AND METHODS FOR SEQUENCING BY SYNTHESIS | ILLUMINA, INC. | 2024-07-25 | — | — | US | claimed |
| US-12037543-B2 | Method for treating production water from the enhanced oil recovery of oil by hydrocyclone in the presence of additives of tetrakis(hydroxymethyl)phosphonium salt type | IFP Energies Nouvelles (FR) | 2024-07-16 | — | — | US | claimed |
| US-20240218443-A1 | METHODS OF SEQUENCING USING 3' BLOCKED NUCLEOTIDES | ILLUMINA, INC. | 2024-07-04 | — | — | US | claimed |
| WO-2024137774-A1 | PALLADIUM CATALYST COMPOSITIONS AND METHODS FOR SEQUENCING BY SYNTHESIS | ILLUMINA, INC. (US) | 2024-06-27 | — | — | WO | claimed |
| CN-117083377-B | Chemo-enzyme coupling method for synthesizing ergothioneine | 中国科学院上海有机化学研究所 | 2024-04-26 | — | — | CN | claimed |
| CN-117916390-A | Compositions and methods for sequencing-by-synthesis | 伊鲁米纳公司 | 2024-04-19 | — | — | CN | claimed |
| EP-4341434-A1 | COMPOSITIONS AND METHODS FOR SEQUENCING BY SYNTHESIS | Illumina, Inc. (US) | 2024-03-27 | — | — | EP | claimed |
| WO-2023213276-A1 | CHEMICAL-ENZYME COUPLING METHOD FOR SYNTHESIZING ERGOTHIONEINE | 中国科学院上海有机化学研究所 | 2023-11-09 | — | — | WO | claimed |
| US-20220396832-A1 | COMPOSITIONS AND METHODS FOR SEQUENCING BY SYNTHESIS | ILLUMINA CAMBRIDGE LIMITED (GB) | 2022-12-15 | — | — | US | claimed |
| WO-2022243480-A1 | COMPOSITIONS AND METHODS FOR SEQUENCING BY SYNTHESIS | ILLUMINA, INC. (US) | 2022-11-24 | — | — | WO | claimed |
| WO-2022150283-A1 | SARS-COV-2 DETECTION | NUCLEASE PROBE TECHNOLOGIES, INC. (US) | 2022-07-14 | — | — | WO | claimed |
| US-20220073810-A1 | METHOD FOR TREATING PRODUCTION WATER FROM THE ENHANCED OIL RECOVERY OF OIL BY HYDROCYCLONE IN THE PRESENCE OF ADDITIVES OF TETRAKIS(HYDROXYMETHYL)PHOSPHONIUM SALT TYPE | IFP Energies Nouvelles (FR) | 2022-03-10 | — | — | US | claimed |
| EP-4748941-A2 | NUCLEOSIDES AND NUCLEOTIDES WITH 3 -HYDROXY BLOCKING GROUPS | Illumina Cambridge Limited (GB) | 2026-05-27 | — | — | EP | disclosed |
| US-20220073810-A1 | METHOD FOR TREATING PRODUCTION WATER FROM THE ENHANCED OIL RECOVERY OF OIL BY HYDROCYCLONE IN THE PRESENCE OF ADDITIVES OF TETRAKIS(HYDROXYMETHYL)PHOSPHONIUM SALT TYPE | IFP Energies Nouvelles (FR) | 2022-03-10 | — | — | US | disclosed |
| WO-2022026696-A1 | METHOD FOR TREATING NEURODEGENERATIVE DISEASES BY ADMINISTERING BENFOTIAMINE OR DERIVATIVE THEREOF | CORNELL UNIVERSITY (US) | 2022-02-03 | — | — | WO | disclosed |